3478 results about "Triglyceride" patented technology

The present invention relates to a hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid or an ester derivative thereof as effective ingredients.According to the present invention, a type IIb and type IV hyperlipemia therapeutic agent having an excellent effect of lowering the cholesterol and triglyceride in blood is provided.

A candle composition has a paraffin wax mixture of a high melting point paraffin wax and a low melting point paraffin wax, and a hydrogenated vegetable oil that is present in a greater amount than the mixture of the varying grades of paraffin wax, and the vegetable oil contains no more than 0.15% free fatty acid, with the remainder being triglycerides. Candles of the composition have good burn characteristics, particularly good fragrance intensity and produce a unique crystallization effect after the first burn.

An integrated process is described for producing biodiesel from oleaginous seeds, preferably castor bean seeds. The inventive process includes a transesterification reaction where the seeds themselves react with anhydrous ethyl alcohol in the presence of an alkaline catalyst. The resulting ethyl esters are then separated by decantation and neutralized and used as fuel for diesel engines, co-solvents for diesel and gasoline mixtures with anhydrous or hydrated ethyl alcohol. The solid fractions may be used as fertilizers, for feeding cattle and as a raw material for producing ethyl alcohol.

Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and / or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.

Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs, particularly fenofibrate, are provided. The compositions comprise a therapeutically effective amount of an active agent and a solubilizer. The solubilizer is selected to effectively solubilize active agent in the composition. The solubilizers employed as part of the invention include: a vitamin E substance; monohydric alcohol esters such as trialkyl citrates, lactones and lower alcohol fatty acid esters; nitrogen-containing solvents; phospholipids; glycerol acetates such as acetin, diacetin and triacetin; glycerol fatty acid esters such as mono-, di- and triglycerides and acetylated mono- and diglycerides; propylene glycol esters; ethylene glycol esters; and combinations thereof. The pharmaceutical dosage forms contain the compositions in a suitable dosage form unit such as a capsule. Methods of treating patients comprising administering the compositions are also provided.

Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and / or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.

Processes for producing hydrocarbons in the gasoline and jet fuel range. The processes involve the thermal decarboxylation of fatty acids, which can be derived from the hydrolysis of triglycerides, which triglycerides can be vegetable oils, animal fats, or combinations thereof. The resulting hydrocarbons can be hydrocracked, and, optionally, isomerized and / or hydrotreated, to yield hydrocarbons in the jet fuel or gasoline range. Where the resulting hydrocarbons include olefinic double bonds, they can alternatively be combined with low molecular weight olefins, and subjected to olefin metathesis to yield hydrocarbons in the jet fuel or gasoline range.

A nutritional supplement, prepared food product, or direct food additive for ingestion by mammals, and methods for preparing such products, are provided. Products of the invention comprise an oxidation-resistant fat-based composition substantially free of exogenous solubilizing and dispersing agents for phytosterols. The fat-based composition includes greater than 25% and less than 75% by weight of one or more triglyceride-based edible oil or fat, and greater than 25% and less than 75% by weight of one or more non-esterified phytosterols. The fat-based composition, when exposed to air, contains a reduced amount of oxidative by-products compared to a similar fat-based composition lacking non-esterified phytosterols. Also provided are methods for reducing plasma cholesterol in mammals, and methods for protecting plasma lipoproteins and cholesterol from oxidation by ingestion of products of the invention.

The present invention relates to a process for preparing an alkyl ester of a fatty acid wherein a transesterification reaction is carried out between a fat or oil and an alcohol in the presence of a catalyst comprising a composite metal oxide having a perovskite structure; and a process for preparing an alkyl ester of a fatty acid wherein a transesterification reaction is carried out between a fat or oil and an alcohol in the presence of a catalyst comprising at least one member selected from the group consisting of oxides, hydroxides and carbonates of alkaline earth metals is used as the catalyst, with the alcohol made into a supercritical state or subcritical state. According to the present invention, the alkyl ester of a fatty acid which can be effectively utilized as a diesel fuel oil or the like can be prepared at high efficiency and on an industrial scale mainly from triglyceride contained in a fat or oil, especially a waste oil.